Complete response to bicalutamide withdrawal prolonged for almost 2 years in patients with metastatic prostate cancer

Hiroshi Hongo, Takeo Kosaka, Mototsugu Oya

研究成果: Article査読

2 被引用数 (Scopus)

抄録

This is the first case report describing a complete response to bicalutamide withdrawal that lasted for almost 2years in a patient with metastatic prostate cancer. An 80-year-old man who had prostate-specific antigen (PSA) level elevation (168.1ng/mL) visited our hospital in February 2010. Bone scintigraphy showed pelvic metastases. We started hormonal therapy with leuprorelin and bicalutamide. The PSA concentration decreased to <0.1ng/mL but started increasing again and reached 1.64ng/mL in October 2012, at which time bicalutamide administration was discontinued. The PSA concentration decreased again and has remained below the limit of sensitivity for almost 2years.

本文言語English
ページ(範囲)150-151
ページ数2
ジャーナルUrology Case Reports
2
5
DOI
出版ステータスPublished - 2014 9

ASJC Scopus subject areas

  • Urology

フィンガープリント 「Complete response to bicalutamide withdrawal prolonged for almost 2 years in patients with metastatic prostate cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル